NUVB Competitors & Alternatives

Compare Nuvation Bio Inc with similar stocks in the same industry

Biotechnology

NUVB

Main Stock
$3.80
-0.26%
Tradestie Score
60
Market Cap
$1.27B
Revenue Growth
242.6%
Analyst Upside
+227.8%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: small molecule oncology inhibitors, targeted cancer therapies
Major Customers 1
None (pre-commercial stage)
Critical Suppliers 3
Contract research organizations (CROs) API manufacturers Clinical trial sites
Direct Ecosystem Rivals 4

Top Competitors

212 stocks in Biotechnology
Company Price Market Cap P/E Score Action
RCUS Arcus Biosciences, Inc.
$15.62
-1.01%
$1.43B - 45 Compare
JANX Janux Therapeutics, Inc. Common Stock
$10.08
-2.04%
$1.42B - 53 Compare
SNDX Syndax Pharmaceuticals, Inc.
$8.72
-4.49%
$1.35B - 61 Compare
RAPP Rapport Therapeutics, Inc. Common Stock
$23.16
-1.82%
$1.32B - 50 Compare
XERS Xeris Biopharma Holdings, Inc. Common Stock
$16.97
+2.11%
$1.29B - 37 Compare
STOK Stoke Therapeutics, Inc. Common Stock
$26.81
-0.45%
$1.29B - 55 Compare
ARDX Ardelyx, Inc.
$2.99
-2.29%
$1.29B - 58 Compare
ZYME Zymeworks Inc.
$26.14
-2.68%
$1.28B 50.7 57 Compare
CVAC CureVac N.V. Ordinary Shares
$4.66
-0.21%
$1.22B 7.0 54 Compare
ATAI ATAI Life Sciences N.V. Common Shares
$7.35
+0.82%
$1.22B - 44 Compare

Data updated: Nov 22, 2026 | Industry: Biotechnology (SIC 2834)

212 stocks in this industry